Affimed NV News

Affimed Announces Acceptance of AFM24 Clinical Abstract For EGFR-wildtype (EGFRwt) Non-Small Cell Lung Cancer (NSCLC) At The 2024 Annual Meeting Of The American Society Of Clinical Oncology

Affimed Announces Acceptance of AFM24 Clinical Abstract For EGFR-wildtype (EGFRwt) Non-Small Cell Lung Cancer (NSCLC) At The 2024 Annual Meeting Of The American Society Of Clinical Oncology

BenzingaApr 24 16:08

Does Affimed N.V. (AFMD) Have the Potential to Rally 263.36% as Wall Street Analysts Expect?

Yahoo FinanceApr 4 21:55

Affimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 1 23:38

Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating

Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating.

MT NewswiresApr 1 23:26

Cantor Fitzgerald Reiterates Overweight on Affimed

Cantor Fitzgerald analyst Li Watsek reiterates Affimed (NASDAQ:AFMD) with a Overweight.

BenzingaApr 1 23:15

Affimed Price Target Raised to $5.00/Share From $1.00 by Stifel

Affimed Price Target Raised to $5.00/Share From $1.00 by Stifel

Dow JonesApr 1 23:03

Truist Financial Sticks to Its Buy Rating for Affimed (AFMD)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Affimed (AFMD – Research Report) today. The company’s shares closed last Thursday at $5.30.

TipRanksApr 1 19:19

Affimed Is Maintained at Buy by HC Wainwright & Co.

Affimed Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 1 18:46

HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Affimed (NASDAQ:AFMD) with a Buy and raises the price target from $5 to $10.

BenzingaApr 1 18:36

Affimed Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 85.19% HC Wainwright & Co. $5 → $10 Maintains Buy 11/15/2023 -7.41% HC Wainwright & Co. → $5 Re

BenzingaApr 1 18:34

Earnings Call Summary | Affimed NV(AFMD.US) Q4 2023 Earnings Conference

The following is a summary of the Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript:Financial Performance:Affimed ended the year 2023 with a reduced cash equivalents and investments of €72 million

Futu NewsMar 29 00:17 · Conference Call

Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M Estimate

Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M Estimate

BenzingaMar 28 20:25

Affimed 2023 Rev EUR8.3M >AFMD

Affimed 2023 Rev EUR8.3M >AFMD

Dow JonesMar 28 18:30

Earnings Scheduled For March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated

BenzingaMar 28 17:24

A Preview Of Affimed's Earnings

Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here's what investors need to know before the announcement.Analysts estimate that Affimed will report

BenzingaMar 27 23:01

Press Release: Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024 MANNHEIM, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ("Affimed" or the "Company"),

Dow JonesMar 21 18:30

Affimed N.V. (AFMD) Upgraded to Buy: Here's What You Should Know

Yahoo FinanceMar 15 00:00

Affimed N.V., Hutchmed, Annexon Among Healthcare Movers

Seeking AlphaMar 14 22:00

Affimed N.V. Shares Resume Trade

Affimed N.V. Shares Resume Trade

BenzingaMar 11 21:00

Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaMar 11 20:55